RESMED INC | 38,625 Euro | +0,02 +0,05 % | |
| WKN: 895878 ISIN: US7611521078 Ticker-Symbol: RME | München | 24.05.13 | 08:05 Uhr |
Branche GesundheitswesenAktienmarkt S&P MidCap 400 |
|
| Zeit | Aktuelle Nachrichten
Sprache: | Leser | Medien | |
|---|---|---|---|---|
| 23.05. | RESMED INC: RMD ANNOUNCES EXCHANGE RATE FOR DIVIDEND | 1 | ASX | |
| 16.05. | XFRA DIVIDEND INFORMATION - 17.05.2013 - 1 | 1.568 | Xetra Newsboard | |
| FOLGENDE WERTPAPIERE WERDEN AM 16.05.2013 CUM DIVIDENDE UND AM 17.05.2013
EX DIVIDENDE GEHANDELT.
THE PRE-DIVIDEND DAY OF THE FOLLOWING SHARES WILL BE 16.05.2013. THE
EX-DIVIDEND DAY WILL BE 17.05.2013.
... Mehr lesen zu: XFRA DIVIDEND INFORMATION - 17.05.2013 - 1 | ||||
| 14.05. | Shares of ResMed Rise to a New 52-Week High | - | SmarTrend | |
| 14.05. | RESMED INC: ResMed and University of Sydney Partnership Agreement | - | ASX | |
| 13.05. | The University of Sydney and ResMed partner to accelerate research in sleep-disordered breathing and biomedical engineering | 37 | PR Newswire | |
| SYDNEY, May 13, 2013 /PRNewswire/ -- The University of Sydney and ResMed Limited today announced a new partnership that includes significant and long-term funding of research at the University, ultimately... Mehr lesen zu: The University of Sydney and ResMed partner to accelerate research in sleep-disordered breathing and biomedical engineering | ||||
| 13.05. | ResMed: 52-Week High Recently Eclipsed | - | SmarTrend | |
| 10.05. | ResMed Looks to Continue to Trade Above its Annual-High Share Price Today | - | SmarTrend | |
| 02.05. | RESMED INC: Form 10Q for Qtr ended March 31, 2013 | - | ASX | |
| 01.05. | RESMED INC - 10-Q, Quaterly Report | - | SEC Filings | |
| 29.04. | ResMed's Earnings Beat; Revs Lag | 2 | Zacks | |
| 26.04. | Goldman Sachs nimmt Resmed in die "conviction buy list" auf | 44 | BörseGo | |
| Goldman Sachs nimmt Resmed in die "conviction buy list" auf
(© BörseGo AG 2013 - Autor: Tobias Krieg, Redakteur) Mehr lesen zu: Goldman Sachs nimmt Resmed in die "conviction buy list" auf | ||||
| 26.04. | ResMed says it has healthcare holy grail | 6 | Yahoo-AU | |
| 26.04. | Resmed books record revenue for March quarter | 3 | The Age | |
| 26.04. | Resmed books record revenue for quarter | - | Yahoo-AU | |
| 26.04. | ResMed Management Discusses Q3 2013 Results - Earnings Call Transcript | - | Seeking Alpha | |
| 26.04. | RESMED INC: Record Financial Results for Q/E & 9 Months Mar 31, 2013 | - | ASX | |
| 25.04. | ResMed Inc. Announces Record Financial Results For The Quarter Ended And Nine Months Ended March 31, 2013 | 43 | PR Newswire | |
| SAN DIEGO, April 25, 2013 /PRNewswire/ -- ResMed Inc. (NYSE: RMD) today announced record revenue and income for the quarter ended March 31, 2013. Revenue for the quarter ended March... Mehr lesen zu: ResMed Inc. Announces Record Financial Results For The Quarter Ended And Nine Months Ended March 31, 2013 | ||||
| 25.04. | ResMed Noninvasive Ventilation Device Cleared by FDA for COPD Treatment | 26 | PR Newswire | |
| SAN DIEGO, April 25, 2013 /PRNewswire/ --One in five patients with stage 3 or 4 chronic obstructive pulmonary disease (COPD) hospitalized for acute exacerbations are readmitted to the hospital within... Mehr lesen zu: ResMed Noninvasive Ventilation Device Cleared by FDA for COPD Treatment | ||||
| 22.04. | Bullish Moving Average Cross by ResMed | 1 | SmarTrend | |
| 16.04. | StockCall Early Morning Insight into St. Jude Medical, Hologic, Navidea Biopharma, ResMed, and Edwards Lifesciences | 38 | PR Newswire | |
| LONDON, April 16, 2013 /PRNewswire/ --
While President Obama's Affordable Care Act (ACA) has been seen by many as being beneficial to the healthcare industry, the reform has been fiercely opposed... Mehr lesen zu: StockCall Early Morning Insight into St. Jude Medical, Hologic, Navidea Biopharma, ResMed, and Edwards Lifesciences | ||||
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten |
|---|---|---|---|
| FRESENIUS MEDICAL CARE | 53,09 | -0,95 % | Fresenius Medical Care: Aktienrückkauf beginnt heute |
| MEDTRONIC | 39,112 | -1,62 % | Medtronic übertrifft Umsatz- und Gewinnprognosen |
| FRESENIUS | 94,50 | -0,89 % | Fresenius-Aktie: Übernahmeschlacht mit Asklepios um RHÖN-KLINIKUM doch noch nicht verloren? |
| DAVITA | 95,98 | -0,76 % | NxStage Announces New Agreements with DaVita |
| INTUITIVE SURGICAL | 386,75 | +5,81 % | SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Intuitive Surgical, Inc. - ISRG |
